2020
DOI: 10.1097/crd.0000000000000292
|View full text |Cite
|
Sign up to set email alerts
|

Arrhythmogenic Right Ventricular Cardiomyopathy Diagnosis

Abstract: Arrhythmogenic right ventricular cardiomyopathy, formerly called “arrhythmogenic right ventricular dysplasia,” is an under-recognized clinical entity characterized by ventricular arrhythmias and a characteristic ventricular pathology. Diagnosis is often difficult due to the nonspecific nature of the disease and the broad spectrum of phenotypic variations. Therefore, consensus diagnostic criteria have been developed which combine electrocardiographic, echocardiographic, cardiac magnetic resonance imaging and hi… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
5
0
3

Year Published

2021
2021
2024
2024

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 9 publications
(8 citation statements)
references
References 59 publications
0
5
0
3
Order By: Relevance
“…A residual cardiomyocyte number < 60% evaluated by a morphometric analysis, with fibrous replacement of the right ventricular free wall myocardium are reported as the main diagnostic criteria [ 14 ]. The myocardiocyte replacement usually originates at the subepicardial level, and then tends to extend to the rest of the wall until it reaches the endocardium [ 21 , 22 , 23 , 24 , 25 ]. In the literature, cardiac wall fatty infiltration alone is not considered as a sufficient morphological hallmark of ARVC [ 10 , 15 , 20 ].…”
Section: Resultsmentioning
confidence: 99%
See 1 more Smart Citation
“…A residual cardiomyocyte number < 60% evaluated by a morphometric analysis, with fibrous replacement of the right ventricular free wall myocardium are reported as the main diagnostic criteria [ 14 ]. The myocardiocyte replacement usually originates at the subepicardial level, and then tends to extend to the rest of the wall until it reaches the endocardium [ 21 , 22 , 23 , 24 , 25 ]. In the literature, cardiac wall fatty infiltration alone is not considered as a sufficient morphological hallmark of ARVC [ 10 , 15 , 20 ].…”
Section: Resultsmentioning
confidence: 99%
“…In the literature, cardiac wall fatty infiltration alone is not considered as a sufficient morphological hallmark of ARVC [ 10 , 15 , 20 ]. However, some authors highlighted that the mere replacement of myocytes with adipose tissue, in the absence of fibrotic phenomena, would seem to be associated with the thickening of the ventricular walls, the complete sparing of the left ventricular wall and the little or complete absence of an inflammatory infiltrate [ 21 , 22 , 23 ]. The left ventricle involvement is increasingly frequent, and it is usually associated with the sparing of the septal wall [ 11 ].…”
Section: Resultsmentioning
confidence: 99%
“…About 39% of patients are mainly right ventricular lesions, 56% of patients have lesions involving bilateral ventricles, 5% of patients' lesions mainly involve the LV 40 . Although ARVC can involve the LV in some cases, the lesions are typically located in the posterolateral subepicardial region, whereas LVAH primarily affects the LV apex 41 . LVEMF is a restricted cardiomyopathy characterized by the deposition of fibrous tissue in the apex and ventricular wall 42 .…”
Section: Discussionmentioning
confidence: 99%
“…40 Although ARVC can involve the LV in some cases, the lesions are typically located in the posterolateral subepicardial region, whereas LVAH primarily affects the LV apex. 41 LVEMF is a restricted cardiomyopathy characterized by the deposition of fibrous tissue in the apex and ventricular wall. 42 While LVEMF shares some similarities with LVAH, such as a short and plump LV and LV apical occlusion, it does not involve the wrapping of the right ventricle around the LV as seen in LVAH.…”
Section: Differential Diagnosismentioning
confidence: 99%
“…Thus multidetector CT could be a reasonable alternative in patients in which the MRI is less likely to be performed 5 . PET-CT can be useful in differentiating ACM from sarcoidosis 30 .…”
mentioning
confidence: 99%